Skip to main content
High RiskFDAfda-F-1675-2016UNDECLARED ALLERGEN

Botanas Los Mart Velitas Candies, 10 pieces, Packaged & Distributed by: Martinez Imports, 190 Passaic St. Passaic, NJ, UPC 1 82729302105

Category
Units Affected
14
Recall Date
April 27, 2016
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1675-2016.

NYSDAM sampled 5 products and they were found to contain undeclared colors, Blue #1, Red #3, Red #40, Yellow #5 and Yellow #6.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1675-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Martinez Imports, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1675-2016.

Martinez Imports, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Martinez Imports, Llc Recall FAQ

Martinez Imports, Llc is the subject of a food safety report: Botanas Los Mart Velitas Candies, 10 pieces, Packaged & Distributed by: Martinez Imports, 190 Passaic St. Passaic, NJ, UPC 1 82729302105. The notice was published on April 27, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 14 units are potentially affected.